Hastings Secures Thai Plant Stake, Targets Q4 2026 Rare Earth Output

Strategic Acquisition Positions Hastings for Early Rare Earth Output

Hastings Technology Metals (ASX:HAS) has taken a significant stride by signing a binding term sheet to acquire a 49% stake in a fully permitted hydrometallurgical Mixed Rare Earth Chloride (MREC) processing plant in Kabin Buri, Thailand. The deal, capped at US$15 million and largely settled via Hastings shares and deferred, production-contingent payments, provides the company with a near-term production hub that sidesteps the capital intensity of building a new plant from scratch.

The Kabin Buri facility, operated by Enuo Holdings Pte Ltd, is fully licensed and boasts a current capacity of 6,000 tonnes per annum (tpa) of MREC output, with expansion potential to 36,000 tpa by 2028. Its location 175km from Laem Chabang Deep Water Port offers direct connectivity to key markets in Australia, China, Japan, Europe, and the US, while Thailand’s lower industrial electricity costs and potential tax incentives further enhance the plant’s operating economics.

Hastings plans to commence commissioning in June 2026, leveraging a recently executed Framework Offtake Agreement securing a minimum of 5,000 tpa of African Monazite Concentrate feedstock with a TREO grade of ≥54%. This feedstock is expected to support commissioning activities from Q2 2026, aiming for first MREC production and cash flow generation by Q4 2026, well ahead of the company’s Yangibana project ramp-up. Hastings’ CEO Vince Catania highlighted this acquisition as a “major transformative step” that offers low capex, low risk, and a clear pathway to early cash flow for shareholders.

Technical Collaboration to Unlock Rare Earth and Niobium Value

In parallel with the acquisition, Hastings has entered a Technical Services and Research Agreement with Enuo to optimise metallurgical processes and beneficiation for its Yangibana and Brockman rare earth and niobium projects in Western Australia. This collaboration targets improved recovery of rare earths and niobium by-products, focusing on flotation behaviour, reagent regimes, and impurity management, which could enhance the commercial viability of shipping beneficiated ore to overseas processing plants.

Niobium, a critical mineral used in high-strength steel and advanced manufacturing, represents a material by-product for Hastings. The maiden niobium resource at Yangibana totals 6.74 million tonnes at 2,305 ppm Nb₂O₅, while Brockman hosts 41.6 million tonnes at 3,540 ppm Nb₂O₅. The Enuo partnership aims to create transferable learnings across both assets, potentially unlocking additional value streams.

Financial Projections and Expansion Pathway

Hastings has revealed a seven-stage caustic-leach hydrometallurgical flowsheet for the Thai plant, designed to convert 5,000 tpa of monazite concentrate into premium-grade MREC flakes. Management’s unaudited estimates project Year 1 gross revenue of US$53.4 million with pretax profits of US$21.6 million, of which Hastings’ 49% share equates to about US$10.6 million. A planned capacity expansion to 12,000 tpa MREC output by Year 2 could double revenue and profits, with a further scale-up to 36,000 tpa envisaged by 2028 to coincide with Yangibana’s production commencement.

The company emphasises the aspirational nature of Phase 2 and 3 production targets, noting they depend on technical feasibility, regulatory approvals, binding feedstock agreements, and funding. The acquisition remains subject to due diligence with completion targeted for June 2026. Notably, commissioning costs will be funded by Enuo and credited against the purchase price, preserving Hastings’ cash position ahead of production.

Funding and Operational Readiness

Hastings ended March 2026 with $2.0 million in cash, down from $4.9 million the prior quarter, reflecting ongoing operating and investing activities including the US$0.5 million refundable deposit on the Thai plant. Subsequent option exercises have generated approximately $3.94 million, bolstering near-term liquidity. The company also retains an At-the-Market facility with Alpha Investment Partners, with around 11 million shares available for placement.

The Board expresses confidence in funding operations through to MREC production, supported by commissioning costs funded by Enuo and the secured monazite feedstock. This financial footing complements operational milestones, with commissioning set for June 2026 and first production targeted for Q4, marking a tangible step toward cash flow generation ahead of the Yangibana project.

Hastings’ strategic pivot to processing via the Thai plant aligns with the US-Thailand Critical Minerals Agreement and Thailand’s 30@30 electric vehicle production policy, potentially unlocking tax incentives through the Board of Investment Thailand, though approvals remain pending.

Hastings is concurrently advancing its Yangibana Rare Earths and Niobium Joint Venture with Wyloo Metals, focusing on mine planning and processing pathways that could see Yangibana concentrate shipped to the Thai plant for value-added processing. This integrated mine-to-market approach underpins Hastings’ ambition to become a significant global supplier of NdPr and associated critical minerals.

Hastings’ acquisition and operational plan reflect a nuanced balance of near-term production readiness and longer-term growth potential, positioning it distinctly in the rare earths sector as it navigates technical, regulatory, and market complexities.

Investors will be watching how the commissioning phase unfolds, the stability of feedstock supply, and whether financial projections materialise amid evolving global demand for rare earths and critical minerals.

Thai Hydromet Plant commissioning is on track to begin in June, with first MREC output expected by year-end, while the African monazite supply agreement secures critical feedstock underpinning this timeline.